Joshua Kuban

Dr. Joshua Kuban, an interventional radiologist at MD Anderson Cancer Center, discusses the significant impacts of NeuWave's discontinuation of its microwave tumor ablation technology. He reflects on how NeuWave reshaped interventional oncology and held over 50% of the microwave market. The conversation explores strategies for adapting to alternative technologies and highlights the evolving landscape of ablation confirmation and emerging robotic technologies. Kuban emphasizes the importance of collaboration and innovation for the future of interventional radiology.